Clinicopathologic study of retinoblastoma including MIB-1, p53, and CD99 immunohistochemistry

Annals of Diagnostic Pathology

Volumn 5, Issue 3, 2001, Pages 148-154

  Schwimer, Christopher J ^a   Prayson, Richard A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

CD99; MIB 1; Ocular tumor; p53; Retinoblastoma

Indexed keywords

CD99 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CELL DEATH; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; EXOPHTHALMOS; FAMILY HISTORY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; LEUKOKORIA; MALE; METASTASIS; MITOSIS INDEX; OPTIC NERVE DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; ROSETTE FORMATION; STRABISMUS; TUMOR CALCINOSIS; TUMOR SUPPRESSOR GENE; VISUAL DISORDER;

EID: 0034944572     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1053/adpa.2001.25406     Document Type: Article

References (33)

1. Historic review of retinoblastoma
2. Retinoblastoma. Origin from a primitive neuroectodermal cell?
3. Tumors of the retina
4. Retinoblastomas, retinocytomas and pseudoretinoblastomas
5. Mutation and cancer: Statistical study of retinoblastoma
6. The role of gene mutations in the genesis of familial cancers
7. Second nonocular tumors in cured unilateral retinoblastoma patients
8. Second primary tumors in patients with retinoblastoma. A review of the literature
9. Detection of the Ki-67 antigen in fixed and wax-embedded sections with monoclonal antibody MIB1
10. p53 and brain tumors: From gene mutations to gene therapy
11. Mutations in the p53 gene occur in diverse human tumour types
12. MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker: Review of more than 600 tumors and the literature experience
13. Immunohistochemical profile of monoclonal antibody 013: Antibody that recognizes glycoprotein p30/32 MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma
14. Immunohistology of lymphoproliferative disorders
15. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms
16. The treatment of retinoblastoma by X-ray and triethylene melamine
17. Current approaches to the diagnosis and management of retinoblastoma
18. Optic nerve involvement in retinoblastoma
19. Histopathologic risk factors in retinoblastoma: A retrospective study of 172 patients treated in a single institution
20. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors
21. Invasion of the optic nerve by retinoblastoma: A clinicopathological study
22. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation
23. Histopathological evaluation for the prognosis of retinoblastoma
24. Proliferation not apoptosis as a prognostic indicator in retinoblastoma
25. Cell death in retinoblastoma: Electron microscopic, immunohistochemical, and DNA fragmentation studies
26. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition is uveal melanoma and retinoblastoma
27. Apoptosis or retinoblastoma: Alternate fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53
28. Nuclear exclusion of wild type p53 in immortalized human retinoblastoma cells
29. Immunohistochemical features of the human retina and retinoblastoma
30. Lack of detection of p53 expression in retinoblastoma tumor cells
31. Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma
32. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors
33. Immunocytochemical study of 12E7 in small round-cell tumours of childhood: An assessment of its sensitivity and specificity